The Galectin Therapeutics GT brand, founded in 2013 (United States), from 2 sister brands and 2214 competing brands. The Galectin Therapeutics GT brand is owned by Galectin Therapeutics, a company listed in New York. The sector of Galectin Therapeutics GT is Biotechnology.

Galectin Therapeutics GT is a brand of Galectin Therapeutics (GALT) Share price

Share price and profitability of the share Galectin Therapeutics (Galectin Therapeutics GT)

Buy Galectin Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 3.40

Portfolio valuation
Galectin Therapeutics (Galectin Therapeutics GT) over 5 years* USD 2.74

Stock market history Galectin Therapeutics (Galectin Therapeutics GT)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more